INVO Fertility, Inc (NASDAQ:IVF) Short Interest Down 19.7% in February

INVO Fertility, Inc (NASDAQ:IVF) saw a significant drop in short interest in the month of February. As of February 13th, there was short interest totaling 284,595 shares, a drop of 19.7% from the January 29th total of 354,428 shares. Based on an average daily volume of 425,821 shares, the days-to-cover ratio is currently 0.7 days. Approximately 4.1% of the shares of the company are sold short. Approximately 4.1% of the shares of the company are sold short. Based on an average daily volume of 425,821 shares, the days-to-cover ratio is currently 0.7 days.

INVO Fertility Stock Down 0.8%

Shares of NASDAQ:IVF traded down $0.01 during midday trading on Thursday, hitting $0.88. The stock had a trading volume of 17,478 shares, compared to its average volume of 10,062,902. The company’s 50-day moving average price is $1.08 and its 200-day moving average price is $3.66. INVO Fertility has a fifty-two week low of $0.71 and a fifty-two week high of $103.68. The company has a market capitalization of $6.12 million, a P/E ratio of 0.00 and a beta of 2.66.

Wall Street Analysts Forecast Growth

Separately, Maxim Group set a $4.00 price target on INVO Fertility in a research note on Tuesday, February 10th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, INVO Fertility presently has a consensus rating of “Moderate Buy” and an average target price of $4.00.

Institutional Investors Weigh In On INVO Fertility

A hedge fund recently bought a new stake in INVO Fertility stock. Citadel Advisors LLC purchased a new position in shares of INVO Fertility, Inc (NASDAQ:IVF) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 66,849 shares of the company’s stock, valued at approximately $51,000. Citadel Advisors LLC owned 1.19% of INVO Fertility as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 12.02% of the company’s stock.

INVO Fertility Company Profile

INVO Fertility (NASDAQ:IVF) is a medical technology company focused on advancing assisted reproductive treatments through innovative in-vivo incubation solutions. The company develops and commercializes devices designed to facilitate fertilization and early embryo development inside a patient’s body, offering an alternative to conventional laboratory-based in vitro fertilization (IVF) techniques.

The company’s flagship product, the INVOcell device, is a single-use, intravaginal incubator that holds a controlled microenvironment for egg and sperm co-incubation.